Form 4: Red Violet Director William Livek Receives RSU Grant

Red Violet, Inc. Director William Paul Livek reported the acquisition of 3,755 restricted stock units, increasing his beneficial ownership to 18,645 RSUs.

Summary

• William Paul Livek, a Director of Red Violet, Inc. (RDVT), acquired 3,755 restricted stock units (RSUs) on December 19, 2025.
• The newly granted RSUs are convertible into common stock on a one-for-one basis and will vest in approximately three equal installments on December 1, 2026, December 1, 2027, and December 1, 2028.
• The grant includes 2,130 RSUs for serving on the Board of Directors and 1,625 RSUs for serving on the Audit Committee.
• Following this transaction, Mr. Livek beneficially owns a total of 18,645 RSUs.
• This total includes previous grants: 1,383 RSUs from January 5, 2024 (vesting December 1, 2026), 2,506 RSUs from November 4, 2024 (vesting in two equal installments on November 1, 2026 and November 1, 2027), and 1,484 RSUs from March 4, 2025 (vesting in two equal installments on November 1, 2026 and November 1, 2027).
• The total also includes 4,517 vested RSUs for which delivery has been deferred until Mr. Livek's separation from the issuer or in case of death or disability.

Sentiment

Score: 7

Explanation: The filing reports a routine equity grant to a director, which is a standard compensation practice. It is mildly positive as it aligns the director's interests with shareholders but does not indicate a significant change in company performance or outlook.

Positives

• The grant of restricted stock units to a director aligns management's interests with those of shareholders, as the value of the compensation is tied to the company's stock performance.

Future Outlook

The future outlook includes the vesting of the newly granted 3,755 restricted stock units in three equal installments on December 1, 2026, December 1, 2027, and December 1, 2028. Additionally, previously granted RSUs are scheduled to vest on various dates in 2026 and 2027.

Industry Context

The grant of restricted stock units to a director is a common practice in publicly traded companies to compensate board members and align their long-term interests with those of the company's shareholders. This is a standard form of equity compensation within the industry.

Comparison to Industry Standards

• The use of restricted stock units (RSUs) as a component of director compensation is a widely adopted practice across various industries, including technology and data analytics companies like Red Violet, Inc.
• The vesting schedule, typically over several years, is consistent with industry norms designed to promote long-term commitment and performance alignment.

Stakeholder Impact

• Shareholders: The equity grant aligns the director's financial interests with the long-term performance of the company, potentially benefiting shareholders through improved governance and strategic decisions.

Next Steps

• The vesting of the 3,755 RSUs in three equal installments on December 1, 2026, December 1, 2027, and December 1, 2028.
• The vesting of previously granted RSUs on their respective schedules in 2026 and 2027.

Key Dates

Recommendation

This Form 4 reports a routine equity grant to a director, which is a standard compensation practice and does not provide new fundamental information to alter an investment thesis. It aligns the director's interests with shareholders but does not indicate a change in company performance or outlook that would warrant a change in investment recommendation.

Keywords

Red Violet, RDVT, Form 4, Insider Transaction, Restricted Stock Units, Equity Compensation, Director Compensation, William Livek